Jiaquan Wu

1.2k citations
24 papers · 874 indexed · h-index 16
Topics
Microbial Natural Products and Biosynthesis (5 papers)Epigenetics and DNA Methylation (5 papers)Cytokine Signaling Pathways and Interactions (4 papers)

In The Last Decade

Jiaquan Wu

24 papers receiving 860 citations

Peers

Jiaquan Wu
Comparison fields: 5 of 91
  • Molecular Biology 602
  • Pharmacology 155
  • Oncology 140
  • Organic Chemistry 115
  • Cell Biology 108
Replace Ayse Batova with:
Ayse Batova United States
GR Pettit United States
Karin von Schwarzenberg Germany
Xavier Billot Canada
Yumiko Hirokawa Australia
Andrew McGown United Kingdom
Murray J. Towle United States
Yoshiharu Mizui Japan
Nerea Allende-Vega France
Eva‐Laure Matera France
Jiaquan Wu relative to Ayse Batova United States Ayse Batova's profile →
Citations per field
00.5×1.5×2.3×
Ayse Batova · 1×
Citations per year

Countries citing papers authored by Jiaquan Wu

Since Specialization
Citations

This map shows the geographic impact of Jiaquan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaquan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaquan Wu more than expected).

Fields of papers citing papers by Jiaquan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaquan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaquan Wu. The network helps show where Jiaquan Wu may publish in the future.

Co-authorship network of co-authors of Jiaquan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaquan Wu. A scholar is included among the top collaborators of Jiaquan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaquan Wu. Jiaquan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 22
2 1
3 7
4 22
5 13
6 35
7 17
8 85
9 118
10 38
11 42
12 154
13 77
14 1
15 34
16 11
17 37
18 8
19 24
20 16

About Jiaquan Wu

Jiaquan Wu is a scholar working on Clinical Biochemistry, Biotechnology and Pharmacology, having authored 24 papers that have together received 874 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (5 papers), Epigenetics and DNA Methylation (5 papers) and Cytokine Signaling Pathways and Interactions (4 papers). The work is most often cited by research in Pharmacology (155 citations), Molecular Biology (602 citations) and Cell Biology (108 citations). Jiaquan Wu has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include David E. Cane, Chaitan Khosla, Huawei Chen, Nicholas Larsen, Nicholas Keen, Tony Cheung, Andrew D. Ferguson, Zhongwu Lai, Scott D. Cowen and Nancy Su. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026